BLTE
Belite Bio Inc
NASDAQ NMS - GLOBAL MARKET· Pharmaceuticals· US· IPO 2022-04-29
$160.66
+3.96 (+2.53%)
last quote
Want the full multi-source brief on BLTE?
The agent pulls regulatory filings, news flow, prediction-market pricing, and macro context — then synthesizes what's not yet in the price.
Today
Open
$160.66
High
$163.36
Low
$157.93
Previous close
$156.70
Fundamentals
Market cap
$7.17B
P/E (TTM)
—
P/S (TTM)
—
P/B
7.28x
Gross margin
—
Operating margin
—
Net margin
—
Rev growth (YoY)
—
EPS growth (YoY)
—
ROE
-26.87%
52W high
$200.00
52W low
$63.51
Beta
-1.20x
Industry peers
by market cap
Upcoming earnings
next 30 days
2026-11-09in 66 days
Q3 2026EPS est $-0.82
Recent SEC filings
CIK 1889109filing-language history →
Recent news
2026-08-27 → 2026-09-03
SeekingAlpha · 10h
Belite Bio, Inc (BLTE) Discusses Prelaunch Strategy and Commercial Opportunity for Tinlarebant in Stargardt Disease Type 1 - Slideshow
2026-09-02. The following slide deck was published by Belite Bio, Inc in conjunction with this event.
SeekingAlpha · 15h
Belite Bio, Inc (BLTE) Discusses Prelaunch Strategy and Commercial Opportunity for Tinlarebant in Stargardt Disease Type 1 Transcript
Belite Bio, Inc (BLTE) Discusses Prelaunch Strategy and Commercial Opportunity for Tinlarebant in Stargardt Disease Type 1 September 2, 2026 8:00 AM...
This is the free preview
The agent layer adds regulatory-language drift detection, cross-venue prediction-market signals, macro overlays, programmable alert rules, overnight briefs, and a grounding verifier on every claim. 7-day Pro trial, no card required.
Start the trial